Modern Diagnostic & Research Centre Peer Comparison

BSE: 544673

₹79.95

₹-4.33 (-5.14%)

As on 24-Sep-2026IST

Market cap

₹121 Cr

Revenue (TTM)

₹78 Cr

P/E Ratio

23

P/B Ratio

2.1

Div. Yield

0 %

Edit

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Market cap (₹ Cr)	121	40,507	33,622	32,934	15,733
Revenue (₹ Cr)	78	4,683	4,213	2,891	857
Net Profit (₹ Cr)	8.97	552.34	190.80	546.30	187.49
Net Margin (%)	11.38	11.55	4.49	18.23	21.32
RoE (%)	55.21	14.93	9.45	23.03	20.58
Price to Earnings	22.98	72.83	164.57	60.77	83.92
Price-To-Book	2.10	9.85	8.89	12.60	15.62

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Operating Revenue	77.95	3,692.35	3,035.10	2,461.40	681.39
Total Income	78.80	3,797.15	3,067.00	2,554.83	699.71
Total Expenditure	59.98	2,831.90	2,242.10	1,765.80	408.17
EBITDA	17.96	860.44	793.00	695.60	273.22
Depreciation	4.19	193.75	177.20	141.92	70.60
EBIT	13.77	666.69	615.80	553.67	202.62
Interest	1.91	74.35	100.40	22.31	26.74
Other Income	0.86	104.81	31.90	93.43	18.32
Exceptional Items	--	-49.90	10.80	--	-1.03
Profit before Tax	12.72	647.26	558.10	624.80	193.16
Provision for Tax	3.76	165.94	143.30	132.55	49.37
Profit after Tax	8.97	481.32	414.80	492.25	143.79

Liabilities (₹ Cr)

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Shareholder's Funds	20.73	3,386.41	2,137.80	2,172.72	799.14
Minority Interest	--	1.10	281.00	33.76	--
Non-Current Liabilities	11.93	726.88	2,421.10	21.34	311.86
Current Liabilities	31.92	618.82	836.20	402.35	162.61
Total Liabilities	64.57	4,766.23	5,689.20	2,713.41	1,273.62

Assets (₹ Cr)

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Non-Current Assets	40.74	3,200.08	4,978.80	1,266.66	966.41
Current Assets	23.83	1,533.12	697.30	1,363.51	307.21
Total Assets	64.57	4,766.23	5,689.20	2,713.41	1,273.62
Total Debt*	22.09	327.88	1,910.90	0.00	0.00
Net Current Assets	-8.08	914.31	-138.90	961.16	144.59
Contingent Liabilities	0.23	88.77	83.80	10.59	0.13

Cashflow (₹ Cr)

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Cash From Operating Activities	13.73	623.76	581.80	568.89	224.47
Cash Flow from Investing Activities	-13.14	-720.94	-1,116.20	-303.16	-181.88
Cash from Financing Activities	-0.22	-97.23	543.10	-334.03	-52.05
Net Cash Inflow / Outflow	0.37	-194.41	8.70	-68.31	-9.45

Ratios

Profitability Ratios

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
ROCE (%)	39.00	20.50	19.02	31.53	30.20
ROE (%)	55.21	15.31	20.92	25.15	19.99
ROA (%)	15.73	10.72	8.74	19.53	12.76
EBIT Margin (%)	24.15	26.14	27.18	32.06	42.79
Net Margin (%)	11.38	12.68	13.52	19.27	20.55
Cash Profit Margin (%)	16.88	18.28	19.51	25.76	31.46

Growth Ratios

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Revenue Growth (%)	16.11	12.74	21.49	10.54	24.39
EBIT Growth (%)	49.46	9.24	24.83	16.31	20.61
Net Profit Growth (%)	54.76	0.68	23.49	35.87	20.19
EPS Growth (%)	54.76	0.65	24.03	35.99	20.67
Book Value Growth (%)	76.27	16.71	16.93	17.68	19.36

Valuation Ratios

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Price / Earnings	0.00	66.85	66.51	21.26	71.86
Price / Book Value	0.00	9.50	11.96	9.79	13.20
Dividend Yield (%)	--	0.04	0.00	0.97	0.20
EV/EBITDA	1.72	32.52	33.22	25.19	35.28
Market Cap (₹ Cr)	0.00	32,181.74	25,571.93	20,714.85	10,333.01

Solvency Ratios

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debt to Equity	1.07	0.10	0.89	0.00	0.00
Short term debt to equity ratio	0.45	--	0.06	--	--
Current Ratio	0.75	2.48	0.83	3.39	1.89
Quick Ratio	0.59	2.37	0.76	3.30	1.86
Interest Coverage	7.67	9.71	6.56	29.01	8.22

Operating Efficiency Ratios

	Modern Diagnostic & Research Centre	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debtors to sales (%)	16.37	7.90	13.03	3.58	2.17
Asset Turnover	1.37	0.82	0.64	0.98	0.60
Receivable days	54.11	25.07	41.48	12.27	8.30
Inventory Days	18.47	6.62	6.82	5.45	2.71
Payable days	163.15	79.17	135.60	134.04	142.28
Cash Conversion Cycle	-90.57	-47.48	-87.31	-116.32	-131.27

Annual
Quarterly